BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17056533)

  • 1. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.
    Stoklasek TA; Schluns KS; Lefrançois L
    J Immunol; 2006 Nov; 177(9):6072-80. PubMed ID: 17056533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells.
    Robinson TO; Hegde SM; Chang A; Gangadharan A; Rivas S; Madakamutil L; Zalevsky J; Miyazaki T; Schluns KS
    J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34375310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
    Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
    J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
    Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
    Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
    Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
    J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
    Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
    Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
    Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
    J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class I and TCR avidity control the CD8 T cell response to IL-15/IL-15Rα complex.
    Stoklasek TA; Colpitts SL; Smilowitz HM; Lefrançois L
    J Immunol; 2010 Dec; 185(11):6857-65. PubMed ID: 21041729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
    Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.
    Zhang M; Ju W; Yao Z; Yu P; Wei BR; Simpson RM; Waitz R; Fassò M; Allison JP; Waldmann TA
    J Immunol; 2012 Jun; 188(12):6156-64. PubMed ID: 22593619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells.
    Schluns KS; Klonowski KD; Lefrançois L
    Blood; 2004 Feb; 103(3):988-94. PubMed ID: 14512307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
    Desbois M; Le Vu P; Coutzac C; Marcheteau E; Béal C; Terme M; Gey A; Morisseau S; Teppaz G; Boselli L; Jacques Y; Béchard D; Tartour E; Cassard L; Chaput N
    J Immunol; 2016 Jul; 197(1):168-78. PubMed ID: 27217584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.
    Zeng R; Spolski R; Finkelstein SE; Oh S; Kovanen PE; Hinrichs CS; Pise-Masison CA; Radonovich MF; Brady JN; Restifo NP; Berzofsky JA; Leonard WJ
    J Exp Med; 2005 Jan; 201(1):139-48. PubMed ID: 15630141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-independent interleukin 15Ralpha signals are required for bystander proliferation.
    Lodolce JP; Burkett PR; Boone DL; Chien M; Ma A
    J Exp Med; 2001 Oct; 194(8):1187-94. PubMed ID: 11602647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
    Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.
    Khan IA; Moretto M; Wei XQ; Williams M; Schwartzman JD; Liew FY
    J Exp Med; 2002 Jun; 195(11):1463-70. PubMed ID: 12045244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
    Rowley J; Monie A; Hung CF; Wu TC
    J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapy.
    Ochoa MC; Fioravanti J; Duitman EH; Medina-Echeverz J; Palazon A; Arina A; Dubrot J; Alfaro C; Morales-Kastresana A; Murillo O; Hervas-Stubbs S; Prieto J; Berraondo P; Melero I
    PLoS One; 2012; 7(12):e52370. PubMed ID: 23285013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.